Pulmonary injury after intravenous hydrocarbon injection

A M Guerguerian1, J Lacroix

  • 1Pediatric Intensive Care Unit, Departments of Pediatrics, Sainte-Justine Hospital, Université de Montréal, Montréal, Québec.

Paediatrics & Child Health
|February 24, 2010
PubMed

Insights

Intravenous hydrocarbon injection can cause severe, yet reversible, pulmonary edema. This case highlights a young man

Area of Science:

  • Toxicology
  • Pulmonary Medicine
  • Case Reports

Background:

  • Hydrocarbon ingestion is a common cause of poisoning.
  • Intravenous injection of hydrocarbons is rare and poorly documented.
  • Pulmonary complications following hydrocarbon injection are not well understood.

Observation:

  • An 18-year-old male presented with acute chest pain, cough, and progressive dyspnea.
  • Initial investigations revealed severe metabolic acidosis and pulmonary edema on chest radiograph.
  • The patient reported self-injection with Varsol, a hydrocarbon mixture, prior to symptom onset.

Findings:

  • Intravenous hydrocarbon injection led to acute, reversible pulmonary edema.
  • The patient's respiratory status and chest radiograph normalized within 7 days.
  • This case demonstrates a direct link between intravenous hydrocarbon administration and pulmonary injury.

Implications:

  • Highlights a potential route of severe pulmonary toxicity from hydrocarbon abuse.
  • Suggests prompt recognition and supportive care are crucial for managing hydrocarbon-induced pulmonary edema.
  • Underscores the need for awareness among healthcare professionals regarding non-traditional routes of substance abuse and their consequences.

Related Concept Videos

Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Pneumothorax II: Pathophysiology01:08

Pneumothorax II: Pathophysiology

Pneumothorax means the presence of air in the pleural space — the thin potential gap between the visceral and parietal pleura. This condition disrupts the normal pressure balance that keeps the lungs inflated, leading to partial or complete collapse of the affected lung.Normal physiologyUnder normal conditions, the pleural space maintains a slightly negative intrapleural pressure, which keeps the lungs expanded against the chest wall. This negative pressure creates a delicate balance between...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.